img

Global Swine Live Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Swine Live Vaccine Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Swine Live Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Swine Live Vaccine market research.
Key manufacturers engaged in the Swine Live Vaccine industry include Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology and Ceva Corporate, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Swine Live Vaccine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Swine Live Vaccine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Live Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Boehringer Ingelheim
Harbin Pharmaceutical Group Bio-vaccine
DHN
Shenzhen BIOCBD Biotechnology
Jinyu Biotechnology
Zhongmu Industry
Qindao Lijian Bio-Tech
Wuhan Keqian Biology
Ceva Corporate
KM Biologics
Nisseiken
Segment by Type
Porcine Reproductive and Respiratory Syndrome Vaccine
Swine Fever Vaccine
Pseudorabies Vaccine
Others

Segment by Application


Breeding Farm
Veterinary Clinic

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Swine Live Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Swine Live Vaccine Market Overview
1.1 Product Overview and Scope of Swine Live Vaccine
1.2 Swine Live Vaccine Segment by Type
1.2.1 Global Swine Live Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Porcine Reproductive and Respiratory Syndrome Vaccine
1.2.3 Swine Fever Vaccine
1.2.4 Pseudorabies Vaccine
1.2.5 Others
1.3 Swine Live Vaccine Segment by Application
1.3.1 Global Swine Live Vaccine Market Value by Application: (2024-2034)
1.3.2 Breeding Farm
1.3.3 Veterinary Clinic
1.4 Global Swine Live Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Live Vaccine Revenue 2018-2034
1.4.2 Global Swine Live Vaccine Sales 2018-2034
1.4.3 Global Swine Live Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Swine Live Vaccine Market Competition by Manufacturers
2.1 Global Swine Live Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Swine Live Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Swine Live Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Swine Live Vaccine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Swine Live Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Swine Live Vaccine, Product Type & Application
2.7 Swine Live Vaccine Market Competitive Situation and Trends
2.7.1 Swine Live Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Swine Live Vaccine Players Market Share by Revenue
2.7.3 Global Swine Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Swine Live Vaccine Retrospective Market Scenario by Region
3.1 Global Swine Live Vaccine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Swine Live Vaccine Global Swine Live Vaccine Sales by Region: 2018-2034
3.2.1 Global Swine Live Vaccine Sales by Region: 2018-2023
3.2.2 Global Swine Live Vaccine Sales by Region: 2024-2034
3.3 Global Swine Live Vaccine Global Swine Live Vaccine Revenue by Region: 2018-2034
3.3.1 Global Swine Live Vaccine Revenue by Region: 2018-2023
3.3.2 Global Swine Live Vaccine Revenue by Region: 2024-2034
3.4 North America Swine Live Vaccine Market Facts & Figures by Country
3.4.1 North America Swine Live Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Swine Live Vaccine Sales by Country (2018-2034)
3.4.3 North America Swine Live Vaccine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Swine Live Vaccine Market Facts & Figures by Country
3.5.1 Europe Swine Live Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Swine Live Vaccine Sales by Country (2018-2034)
3.5.3 Europe Swine Live Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Live Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Swine Live Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Swine Live Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific Swine Live Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Swine Live Vaccine Market Facts & Figures by Country
3.7.1 Latin America Swine Live Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Swine Live Vaccine Sales by Country (2018-2034)
3.7.3 Latin America Swine Live Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Live Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Live Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Swine Live Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Swine Live Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Live Vaccine Sales by Type (2018-2034)
4.1.1 Global Swine Live Vaccine Sales by Type (2018-2023)
4.1.2 Global Swine Live Vaccine Sales by Type (2024-2034)
4.1.3 Global Swine Live Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Swine Live Vaccine Revenue by Type (2018-2034)
4.2.1 Global Swine Live Vaccine Revenue by Type (2018-2023)
4.2.2 Global Swine Live Vaccine Revenue by Type (2024-2034)
4.2.3 Global Swine Live Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Swine Live Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Swine Live Vaccine Sales by Application (2018-2034)
5.1.1 Global Swine Live Vaccine Sales by Application (2018-2023)
5.1.2 Global Swine Live Vaccine Sales by Application (2024-2034)
5.1.3 Global Swine Live Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Swine Live Vaccine Revenue by Application (2018-2034)
5.2.1 Global Swine Live Vaccine Revenue by Application (2018-2023)
5.2.2 Global Swine Live Vaccine Revenue by Application (2024-2034)
5.2.3 Global Swine Live Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Swine Live Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Boehringer Ingelheim Swine Live Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Harbin Pharmaceutical Group Bio-vaccine
6.2.1 Harbin Pharmaceutical Group Bio-vaccine Corporation Information
6.2.2 Harbin Pharmaceutical Group Bio-vaccine Description and Business Overview
6.2.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio
6.2.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
6.3 DHN
6.3.1 DHN Corporation Information
6.3.2 DHN Description and Business Overview
6.3.3 DHN Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 DHN Swine Live Vaccine Product Portfolio
6.3.5 DHN Recent Developments/Updates
6.4 Shenzhen BIOCBD Biotechnology
6.4.1 Shenzhen BIOCBD Biotechnology Corporation Information
6.4.2 Shenzhen BIOCBD Biotechnology Description and Business Overview
6.4.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio
6.4.5 Shenzhen BIOCBD Biotechnology Recent Developments/Updates
6.5 Jinyu Biotechnology
6.5.1 Jinyu Biotechnology Corporation Information
6.5.2 Jinyu Biotechnology Description and Business Overview
6.5.3 Jinyu Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Jinyu Biotechnology Swine Live Vaccine Product Portfolio
6.5.5 Jinyu Biotechnology Recent Developments/Updates
6.6 Zhongmu Industry
6.6.1 Zhongmu Industry Corporation Information
6.6.2 Zhongmu Industry Description and Business Overview
6.6.3 Zhongmu Industry Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zhongmu Industry Swine Live Vaccine Product Portfolio
6.6.5 Zhongmu Industry Recent Developments/Updates
6.7 Qindao Lijian Bio-Tech
6.6.1 Qindao Lijian Bio-Tech Corporation Information
6.6.2 Qindao Lijian Bio-Tech Description and Business Overview
6.6.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio
6.7.5 Qindao Lijian Bio-Tech Recent Developments/Updates
6.8 Wuhan Keqian Biology
6.8.1 Wuhan Keqian Biology Corporation Information
6.8.2 Wuhan Keqian Biology Description and Business Overview
6.8.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Wuhan Keqian Biology Swine Live Vaccine Product Portfolio
6.8.5 Wuhan Keqian Biology Recent Developments/Updates
6.9 Ceva Corporate
6.9.1 Ceva Corporate Corporation Information
6.9.2 Ceva Corporate Description and Business Overview
6.9.3 Ceva Corporate Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ceva Corporate Swine Live Vaccine Product Portfolio
6.9.5 Ceva Corporate Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 KM Biologics Swine Live Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
6.11 Nisseiken
6.11.1 Nisseiken Corporation Information
6.11.2 Nisseiken Swine Live Vaccine Description and Business Overview
6.11.3 Nisseiken Swine Live Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Nisseiken Swine Live Vaccine Product Portfolio
6.11.5 Nisseiken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Live Vaccine Industry Chain Analysis
7.2 Swine Live Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Live Vaccine Production Mode & Process
7.4 Swine Live Vaccine Sales and Marketing
7.4.1 Swine Live Vaccine Sales Channels
7.4.2 Swine Live Vaccine Distributors
7.5 Swine Live Vaccine Customers
8 Swine Live Vaccine Market Dynamics
8.1 Swine Live Vaccine Industry Trends
8.2 Swine Live Vaccine Market Drivers
8.3 Swine Live Vaccine Market Challenges
8.4 Swine Live Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Swine Live Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Swine Live Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Swine Live Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Swine Live Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Swine Live Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Swine Live Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Swine Live Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Swine Live Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Swine Live Vaccine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Swine Live Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Swine Live Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Swine Live Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Live Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Live Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Live Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Swine Live Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Swine Live Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Swine Live Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Swine Live Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Swine Live Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Swine Live Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Swine Live Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Swine Live Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Swine Live Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Swine Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Swine Live Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Swine Live Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Swine Live Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Swine Live Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Swine Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Swine Live Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Swine Live Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Swine Live Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Swine Live Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Swine Live Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Swine Live Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Swine Live Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Swine Live Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Swine Live Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Swine Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Swine Live Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Swine Live Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Swine Live Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Swine Live Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Swine Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Swine Live Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Swine Live Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Swine Live Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Swine Live Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Swine Live Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Swine Live Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Swine Live Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Swine Live Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Swine Live Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Swine Live Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Swine Live Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Swine Live Vaccine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Swine Live Vaccine Price (USD/Unit) by Type (2024-2034)
Table 60. Global Swine Live Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Swine Live Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Swine Live Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Swine Live Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Swine Live Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Swine Live Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Swine Live Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Swine Live Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Swine Live Vaccine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Swine Live Vaccine Price (USD/Unit) by Application (2024-2034)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Boehringer Ingelheim Swine Live Vaccine Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Harbin Pharmaceutical Group Bio-vaccine Corporation Information
Table 76. Harbin Pharmaceutical Group Bio-vaccine Description and Business Overview
Table 77. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product
Table 79. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 80. DHN Corporation Information
Table 81. DHN Description and Business Overview
Table 82. DHN Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. DHN Swine Live Vaccine Product
Table 84. DHN Recent Developments/Updates
Table 85. Shenzhen BIOCBD Biotechnology Corporation Information
Table 86. Shenzhen BIOCBD Biotechnology Description and Business Overview
Table 87. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product
Table 89. Shenzhen BIOCBD Biotechnology Recent Developments/Updates
Table 90. Jinyu Biotechnology Corporation Information
Table 91. Jinyu Biotechnology Description and Business Overview
Table 92. Jinyu Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Jinyu Biotechnology Swine Live Vaccine Product
Table 94. Jinyu Biotechnology Recent Developments/Updates
Table 95. Zhongmu Industry Corporation Information
Table 96. Zhongmu Industry Description and Business Overview
Table 97. Zhongmu Industry Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Zhongmu Industry Swine Live Vaccine Product
Table 99. Zhongmu Industry Recent Developments/Updates
Table 100. Qindao Lijian Bio-Tech Corporation Information
Table 101. Qindao Lijian Bio-Tech Description and Business Overview
Table 102. Qindao Lijian Bio-Tech Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Qindao Lijian Bio-Tech Swine Live Vaccine Product
Table 104. Qindao Lijian Bio-Tech Recent Developments/Updates
Table 105. Wuhan Keqian Biology Corporation Information
Table 106. Wuhan Keqian Biology Description and Business Overview
Table 107. Wuhan Keqian Biology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Wuhan Keqian Biology Swine Live Vaccine Product
Table 109. Wuhan Keqian Biology Recent Developments/Updates
Table 110. Ceva Corporate Corporation Information
Table 111. Ceva Corporate Description and Business Overview
Table 112. Ceva Corporate Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Ceva Corporate Swine Live Vaccine Product
Table 114. Ceva Corporate Recent Developments/Updates
Table 115. KM Biologics Corporation Information
Table 116. KM Biologics Description and Business Overview
Table 117. KM Biologics Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. KM Biologics Swine Live Vaccine Product
Table 119. KM Biologics Recent Developments/Updates
Table 120. Nisseiken Corporation Information
Table 121. Nisseiken Description and Business Overview
Table 122. Nisseiken Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Nisseiken Swine Live Vaccine Product
Table 124. Nisseiken Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Swine Live Vaccine Distributors List
Table 128. Swine Live Vaccine Customers List
Table 129. Swine Live Vaccine Market Trends
Table 130. Swine Live Vaccine Market Drivers
Table 131. Swine Live Vaccine Market Challenges
Table 132. Swine Live Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Swine Live Vaccine
Figure 2. Global Swine Live Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Swine Live Vaccine Market Share by Type in 2024 & 2034
Figure 4. Porcine Reproductive and Respiratory Syndrome Vaccine Product Picture
Figure 5. Swine Fever Vaccine Product Picture
Figure 6. Pseudorabies Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Swine Live Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Swine Live Vaccine Market Share by Application in 2024 & 2034
Figure 10. Breeding Farm
Figure 11. Veterinary Clinic
Figure 12. Global Swine Live Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Swine Live Vaccine Market Size (2018-2034) & (US$ Million)
Figure 14. Global Swine Live Vaccine Sales (2018-2034) & (K Units)
Figure 15. Global Swine Live Vaccine Average Price (USD/Unit) & (2018-2034)
Figure 16. Swine Live Vaccine Report Years Considered
Figure 17. Swine Live Vaccine Sales Share by Manufacturers in 2024
Figure 18. Global Swine Live Vaccine Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Swine Live Vaccine Players: Market Share by Revenue in 2024
Figure 20. Swine Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Swine Live Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Swine Live Vaccine Sales Market Share by Country (2018-2034)
Figure 23. North America Swine Live Vaccine Revenue Market Share by Country (2018-2034)
Figure 24. United States Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Swine Live Vaccine Sales Market Share by Country (2018-2034)
Figure 27. Europe Swine Live Vaccine Revenue Market Share by Country (2018-2034)
Figure 28. Germany Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Swine Live Vaccine Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Swine Live Vaccine Revenue Market Share by Region (2018-2034)
Figure 35. China Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Swine Live Vaccine Sales Market Share by Country (2018-2034)
Figure 45. Latin America Swine Live Vaccine Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Swine Live Vaccine Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Swine Live Vaccine Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Swine Live Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Swine Live Vaccine by Type (2018-2034)
Figure 55. Global Revenue Market Share of Swine Live Vaccine by Type (2018-2034)
Figure 56. Global Swine Live Vaccine Price (USD/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Swine Live Vaccine by Application (2018-2034)
Figure 58. Global Revenue Market Share of Swine Live Vaccine by Application (2018-2034)
Figure 59. Global Swine Live Vaccine Price (USD/Unit) by Application (2018-2034)
Figure 60. Swine Live Vaccine Value Chain
Figure 61. Swine Live Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed